Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Guidelines search
Search Guidelines
Guidelines search
Apply
Open
Close
Archived Guidelines
(1)
Guidelines for Caring for People With HIV Displaced by Disasters
(4)
HIV Clinical Guidelines: Adult and Adolescent ARV
(18)
HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections
(34)
HIV Clinical Guidelines: Pediatric ARV
(19)
HIV Clinical Guidelines: Pediatric Opportunistic Infections
(29)
Perinatal HIV Clinical Guidelines
(18)
Search Results
341 – 360
of
369
Etravirine
Gastrointestinal Effects
Atazanavir (Reyataz, ATV)
Nelfinavir (Viracept, NFV)
Table 14. Antiretroviral Drug Use in Pregnant People With HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | Overview
Appendix B: Web-Based Resources for Treating and Preventing HIV
Dyslipidemia
Table 4. Common Drugs Used for Treatment of Opportunistic Infections in Children With HIV: Preparations and Major Toxicities
Tenofovir AF
Modifying Antiretroviral Regimens in Children With Sustained Virologic Suppression on Antiretroviral Therapy
Abacavir (Ziagen, ABC)
Rilpivirine
Figure 1. Recommended Immunization Schedule for Children with HIV Infection Aged 0 through 18 Years; United States, 2019
Tipranavir
Appendix B: Mycobacterium avium Complex
What’s New in the Guidelines
Baseline Evaluation
Drug-Drug Interactions: Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors
Overview
Drug-Drug Interactions: Integrase Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors or Protease Inhibitors
Pagination
First page
‹‹
Previous page
‹
…
Page
15
Page
16
Page
17
Current page
18
Page
19
Next page
›
Last page
››